The SATURİSTA Device (SATURİSTA)
Development and Pilot Evaluation of an Artificial Intelligence-Assisted System for Automated Oxygen Flow Regulation: The Saturista Device
This study aims to evaluate the functional performance and feasibility of the Saturista system, a novel device designed for automated oxygen flow regulation based on continuous monitoring of oxygen saturation (SpO₂). The system integrates real-time physiological monitoring, wireless data transmission, and centralized visualization to support timely detection of oxygen desaturation and clinical decision-making.
A pilot feasibility study will be conducted in healthy volunteers using a scenario-based protocol, including baseline monitoring, controlled desaturation, probe disconnection, and signal recovery. The primary objective is to assess the system's ability to generate alarms in response to changes in SpO₂ and to display data in real time. Secondary objectives include evaluation of response time, signal management, and overall system stability.
調査の概要
状態
条件
詳細な説明
The Saturista system is a novel, integrated platform designed to support automated oxygen therapy management through continuous monitoring of oxygen saturation (SpO₂) and real-time decision support. The system combines pulse oximetry-based sensing, wireless data transmission, a cloud-based data infrastructure, and a web-based user interface within a distributed closed-loop control architecture.
In conventional clinical practice, oxygen therapy is typically adjusted manually based on intermittent assessment of oxygen saturation. This approach may delay recognition of physiological deterioration and timely intervention. The Saturista system addresses this limitation by enabling continuous monitoring, automated alarm generation, and centralized visualization of patient data at the nursing station.
The system consists of three main components: (i) a pulse oximetry-based monitoring module, (ii) an embedded device with wireless communication capabilities that regulates oxygen flow via a pneumatic valve mechanism, and (iii) a cloud-based software platform that processes physiological data and provides real-time visualization and alarm management.
This study is designed as a pilot feasibility study conducted in healthy volunteers to evaluate the technical and functional performance of the system. A scenario-based testing protocol will be applied, including baseline monitoring, controlled desaturation through short-duration breathing maneuvers, probe disconnection, and signal recovery. These scenarios simulate common clinical monitoring conditions and allow assessment of system responsiveness and reliability.
The primary outcome measures include the system's ability to detect decreases in SpO₂ and generate appropriate alarms, as well as its capacity to display physiological data in real time. Secondary outcomes include system response time, detection of signal loss, recovery performance, and overall operational stability.
The findings of this study are expected to provide preliminary evidence regarding the feasibility and functional performance of the Saturista system and to inform the design of future clinical studies in patient populations.
研究の種類
入学 (推定)
連絡先と場所
研究場所
-
-
-
Istanbul、トルコ（Türkiye）
- Istinye University
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
The study population consists of healthy adult volunteers recruited for a pilot feasibility evaluation of the Saturista system. Participants are individuals without known respiratory or cardiovascular disease and with normal baseline oxygen saturation levels.
The purpose of selecting a healthy population is to assess the technical performance and functional reliability of the system under controlled conditions before clinical testing in patient populations. All participants will undergo a structured, scenario-based testing protocol, including baseline monitoring, controlled desaturation maneuvers within safe physiological limits, probe disconnection, and signal recovery.
This population allows for standardized assessment of the system's ability to monitor SpO₂, generate alarms, display real-time data, and manage signal-related events without the confounding effects of underlying clinical conditions.
説明
Inclusion Criteria:
- Healthy adult volunteers aged 18 years or older
- Resting oxygen saturation (SpO₂) within the normal range at baseline
- Ability to understand the study procedures and provide written informed consent
- Willingness to participate in all planned testing scenarios
Exclusion Criteria:
- History of chronic respiratory disease, including asthma, chronic obstructive pulmonary disease, or interstitial lung disease
- Known cardiovascular disease or any condition that may affect oxygen saturation or hemodynamic stability
- Current respiratory symptoms, acute infection, or fever at the time of participation
- Anemia, peripheral circulatory disorders, or any condition that may interfere with pulse oximetry measurements
- Skin lesions, deformity, or injury at the intended probe placement site
- Pregnancy
- History of syncope, intolerance to short-duration breath-holding, or any condition that may increase risk during testing
- Inability or unwillingness to comply with study procedures
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Healthy Adult Volunteers (Pilot Feasibility Cohort)
This cohort includes healthy adult volunteers participating in a pilot feasibility study to evaluate the functional performance of the Saturista system. Participants will undergo a structured, scenario-based testing protocol under controlled conditions. The protocol includes baseline monitoring, controlled desaturation through short-duration breathing maneuvers, probe disconnection, and signal recovery. The purpose of this cohort is to assess the system's ability to monitor oxygen saturation (SpO₂), generate alarms in response to predefined threshold changes, display data in real time, and manage signal interruption and recovery. No therapeutic intervention is applied, and all procedures are conducted within safe physiological limits under supervision. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Real-Time Data Display Performance
時間枠：Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
Proportion of measurements successfully displayed on the user interface in real time during all testing scenarios.
|
Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Alarm Response Time
時間枠：Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
Time (in seconds) between a decrease in SpO₂ below the predefined threshold and activation of the system alarm.
|
Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Display Delay
時間枠：Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
Time (in seconds) between SpO₂ measurement and visualization on the user interface.
|
Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
|
Signal Recovery Performance
時間枠：Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
Proportion of scenarios in which the system successfully resumes valid data acquisition and terminates alarms after probe reconnection.
|
Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
|
Technical Reliability
時間枠：Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
Frequency of technical issues or system failures observed during testing sessions.
|
Day 1, during multiple predefined simulation scenarios applied sequentially within a single testing session
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Hansen EF, Hove JD, Bech CS, Jensen JS, Kallemose T, Vestbo J. Automated oxygen control with O2matic(R) during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018 Dec 14;13:3997-4003. doi: 10.2147/COPD.S183762. eCollection 2018.
- McMullan J, Hart KW, Barczak C, Lindsell CJ, Branson R. Supplemental Oxygen Requirements of Critically Injured Adults: An Observational Trial. Mil Med. 2016 Aug;181(8):767-72. doi: 10.7205/MILMED-D-15-00356.
- Douin DJ, Rice JD, Xiao M, Beaty L, Guo C, Withers C, Sullivan A, Anderson EL, Cheng AC, Banasiewicz MK, Semler MW, Lloyd BD, Maiga A, Gibbs KW, Stettler GR, Khan A, Sally MB, Wright FL, Aggarwal N, Bebarta VS, Ginde AA; SAVE-O2 AI Investigators. Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol. BMJ Open. 2026 Jan 28;16(1):e110739. doi: 10.1136/bmjopen-2025-110739.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。